-
innovative research in the laboratory, in patients and in populations. BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise
-
of murine models of high-grade lymphoma with the aim of providing pre-clinical evidence to support the development of metabolic inhibitors as novel treatments for lymphoma, alone or in combination with
-
, QMUL. The Institute comprises approximately 350 staff based in four academic Centres and one Public Engagement Centre and supports a combined total of c750 postgraduate research and taught students
-
Vitro Models. The project aims to use organ-on-a-chip technology combined with bioengineering approaches to develop, validate and use a suite of vascularised human tendon-chip models. These high quality